THE NECESSITY FOR ALBUMIN PRODUCTS IN ABO-INCOMPATIBLE RENAL TRANSPLANTATION
-
- Moriya Tomomi
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Okamoto Yoshio
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Kobayashi Hirohito
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Matsuda Kazuki
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Kubota Tomoaki
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Ogata Yasutaka
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Oikawa Miyuki
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Lee Maiko
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Kinoshita Akemi
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Aoki Takako
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Chino Mineko
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Okada Shin-ichi
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Kohgen Yumi
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Aoki Masahiro
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Nakabayashi Kyoko
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Konno Mayumi
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Utsugisawa Taiju
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Ogura Hiromi
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
-
- Kanno Hitoshi
- Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University
Bibliographic Information
- Other Title
-
- ABO血液型不適合腎移植におけるアルブミン製剤の必要性
Search this article
Abstract
The Ministry of Health, Labour and Welfare evaluated the appropriateness of institutional standards for transfusion management systems and the adequate use of blood products in 2012. Our hospital fulfilled standards in a transfusion management system, but did not receive an additional credit for adequate use of blood products due to excess use of albumin as well as fresh frozen plasma in plasma exchange, cardiovascular surgery and organ transplantation. Regarding albumin consumption, total use of albumin products exceeded 180 kg per year, representing over 0.5% of the total use in Japan. In this study, we surveyed albumin consumption in each clinical department, and noted that approximately 12% of albumin was used in plasma exchange accompanying renal transplantation. When compared between ABO-matched and -mismatched renal transplantation, the former consumed 83.5±17.4 g and the latter used 325.6±30.4 g albumin per transplantation. In 2011, the total number of renal transplantations was 185, and about 1/3 were from ABO-mismatched donors. It is absolutely necessary for ABO-mismatched renal transplantation to remove anti-A or B antibody before operation through 2 to 4 rounds of plasma exchange. Over 200,000 patients suffer from chronic renal insufficiency in Japan, and the shortage of donors has become a serious problem. To overcome this, ABO-mismatched renal plantation must be encouraged. Against this background, we propose that a multi-institutional collaborative study is required to survey the amount of albumin used in plasma exchange in renal transplantation. We also propose that the guidelines for appropriate use of albumin for plasma exchange should be reconsidered.
Journal
-
- Japanese Journal of Transfusion and Cell Therapy
-
Japanese Journal of Transfusion and Cell Therapy 60 (4), 521-526, 2014
The Japan Society of Transfusion Medicine and Cell Therapy
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001205270856704
-
- NII Article ID
- 130004688193
-
- ISSN
- 18830625
- 18813011
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- KAKEN
-
- Abstract License Flag
- Disallowed